November 21, 2022

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

Registration is now open for the NRG Oncology Winter 2023 Meeting to be held both in Orlando and virtually, January 26-28, 2023.

Click here to register today!

(Registrations after January 3^rd will incur a late registration fee)

Now accepting applications for travel awards - NRG 2023 winter meeting

All travel award applications have been consolidated into one form. All applications must be received by December 2, 2022. Awardees will be notified by December 9, 2022. Please be sure to attach any required materials, when applicable, to complete your application. 

The available award categories are NRG NCORP Award (2 Awards), NRG Early Career & New Investigators Travel Award, and the Machtay Young Investigators Award. More information regarding each award category is available on our NRG Oncology website in the NRG 2023 Meeting webpages. If you have any questions regarding travel awards, please reach out to meeting-reg@nrgoncology.org.

AMENDMENTS

GYNECOLOGIC

NRG-GY009: Amendment 13; version date: October 13, 2022 (posted on CTSU)

LUNG

NRG-LU005: Amendment 9, version date November 3, 2022 (posted on CTSU)

HEAD & NECK

NRG-HN001 (Sites in Canada only): The NOL and additional forms for amendment 9 are posted on CTSU.

FORM UPDATES

BRAIN

NRG-BN012

The Blank Rave Forms document has been updated. The updated version is posted on CTSU. Please begin using these new forms immediately.

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Actively Recruiting MALE Patients only. Read More

2. CANCER PREVENTION & CONTROL

NRG-CC005/FORTE: Letter for GI Practices (posted on CTSU)

3. GYNECOLOGIC

GOG-0210: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

GOG-0225: To provide the most accurate and reliable assessment possible, sites are asked to answer any outstanding queries and update the Overall Survival status and last contact date for all patients enrolled on GOG-0225 no later than Friday, December 2, 2022. This trial utilizes the SEDES EDC system for form entry. If site personnel need access to SEDES for this study, please contact support@nrgoncology.org. SEDES can be accessed via the GOG Web menu.

NRG-GY012 and NRG-GY023 – BLOOD PRESSURE CUFF SUPPLY IS VERY LIMITED - Please be advised that VWR has a very limited supply of blood pressure cuffs at present. Please check your supplies on site for any overlooked cuffs prior to ordering. Thank you for your cooperation.  

4. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, December 14, 2022.

DRUG SAFETY AND INVESTIGATOR’S BROCHURE (IB) UPDATES

Drug Safety and Investigator’s Brochure updates have been issued for the following studies:

*The current version of the Investigator Brochure Documents for Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)-sponsored trials are available for access via the Cancer Therapy Evaluation Program (CTEP) Online Agent Order Processing (OAOP) website. Log-in using your Identity and Access Management (IAM) username and password credentials and provide the requested information to access the document.

Every site principal investigator is responsible for reviewing this document. The Investigator Brochure is for use by the site principal investigator and any study personnel under his/her supervision who need to know the contents for the conduct of a clinical trial, including Institutional Review Board(s) or Independent Ethics Committee(s).

Biospecimen Bank San Francisco Shipping Update

Due to an ongoing strike by some employees at the University of California, the NRG Oncology Biospecimen Bank San Francisco located at UCSF is requesting sites to use Fed Ex for all shipments to the bank until further notice. UPS deliveries to the San Francisco bank cannot be guaranteed during the strike. Please use Federal Express for specimen shipments or delay non-urgent shipments at this time. Please contact the lab at NRGBB@UCSF.EDU prior to resuming shipping by UPS for an update after Thanksgiving.

Reminder: Thanksgiving Holiday Closure Information

Please see the memoranda posted on the CTSU website for Thanksgiving holiday closure information for the NRG Oncology Operations Offices, Statistics and Data Management Centers (SDMCs), Biospecimen Banks, Serum Bank, and McKesson's Clinical Research Services.

PUBLICATIONS REMINDERS

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.

JOURNAL ARTICLES

Magliocco AM, Moughan J, Miyamoto DT, Simko J, Shipley WU, Gray PJ, Hagan MP, Parliament M, Tester WJ, Zietman AL, McCarthy S, Saeed-Vafa D, Xiong Y, Ayral T, Hartford AC, Patel A, Rosenthal SA, Chafe S, Greenberg R, Schwartz MA, Augspurger ME, Keech JA Jr, Winter KA, Feng FY, Efstathiou JA. Analysis of MRE11 and Mortality Among Adults with Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy. JAMA Netw Open. 2022 Nov 1;5(11):e2242378. doi: 10.1001/jamanetworkopen.2022.42378. PMID: 36383379. Read more

Please note the following upcoming meeting and abstract submission deadline dates

UPCOMING MEETINGS

American Society of Clinical Oncology (ASCO) GI; Jan 19-21, 2023; San Francisco, CA

Radiological Society of North America (RSNA); Nov 27-Dec 1, 2022; Chicago, IL

San Antonio Breast Cancer Symposium (SABCS); Dec 6-10, 2022; San Antonio, TX

Society of Urologic Oncology (SUO); Nov 30-Dec 2, 2022; San Diego, CA

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Association for Cancer Research (AACR); Apr 14-19, 2023; Orlando, FL; LBA Jan 12, 2023

American Head & Neck Society (AHNS); July 8-12, 2023; Montreal, QC Canada; meeting submission deadline Jan 24, 2023; meeting submission deadline Feb 14, 2023; LBA Mar 16, 2023, Noon (EST)

American Society of Clinical Oncology (ASCO); Jun 2-6, 2023; Chicago, IL; due to publications committee Jan 24, 2023; meeting submission deadline Feb 14, 2023, 1159 pm EST; LBA Mar 16, 2023, Noon (EST)

American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium; Feb 16-18, 2023; San Francisco, CA; LBA Dec 13, 2022, Noon (EST)

ESMO Gynaecological Cancers Annual Congress 2023; Feb 23-24, 2023; Barcelona, Spain; meeting submission deadline Nov 29, 2022, TIP 9 pm CET (CntEurTime)

European Society for Radiotherapy and Oncology (ESTRO); May 12-16, 2023; Vienna, Austria; LBA Jan 18, 2023, 9 pm EST

Society of Surgical Oncology (SSO 2023); Surgical Cancer Care; Mar 22-25, 2023; Boston, MA; LBA Dec 9, 2022

St. Gallen Breast Cancer Conference (SG-BCC); Mar 15-18, 2023; Vienna, Austria; due to publications committee Dec 2, 2022; meeting sub meeting submission deadline Feb 14, 2023, 1159 pm EST; LBA Mar 16, 2023, Noon

American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium; Feb 16-18, 2023; San Francisco, CA; LBA Dec 13, 2022, Noon (EST)

ESMO Gynaecological Cancers Annual Congress 2023; Feb 23-24, 2023; Barcelona, Spain; meeting submission deadline Nov 29, 2022, TIP 9 pm CET (CntEurTime)